RAD-140

Category: pharmacological

Aliases: Testolone

Pharmacological Mechanism

Developed by Radius Health as a non-steroidal AR agonist for cancer cachexia + breast cancer. High AR selectivity with anabolic:androgenic ratio ~90:1 in preclinical models. Clinical development halted; research/illicit use continues.

Half-Life (t½)

PO: 44.7h

Dosing Guidelines

• PO: Typical 13.3mg (Range: 10 - 20 mg)

Target Organ Systems

• endocrine
• reproductive
• musculoskeletal